This course aims to provide a summary of the 2022 updates to the National Institute for Health and Care Excellence (NICE) guidelines on the management of people with type 2 diabetes. It will consider the change in emphasis from a target-driven and gluco-centric approach towards a greater focus on cardio-renal risk reduction. This shift in focus places the assessment of current and future cardiovascular risk at the centre of treatment. We will consider the opportunities this brings to offer our patients a more personalised approach to pharmacological treatment of diabetes in primary care, including the need to avoid intensive treatment in frailer patients. The course doesn’t reflect the 2025 update to the NICE heart failure guidance or the 2026 update to the NICE diabetes guidance and users should use the course with that in mind.
Production, editorial, and distribution owned by the Royal College of General Practitioners.
Curriculum: Cardiovascular Health, Metabolic Problems and Endocrinology
CPD Points: 0.75
Time to complete this course: 45 minutes
Date of publication: 15 February 2023
Mode: Course
Remove from search results: No
Podcast icon: No
Course index: Show
Section titles: Hide
Progress Doughnut: Hide